Clinical trial
Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendin
NCT03889496 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendin
- Lead sponsor
- Radboud University Medical Center
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- November 16, 2015
- Completion date
- June 14, 2021
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.